Kidney Disease Flashcards

1
Q

What is microalbuminuria

A

30-300 mg/gtoo small to show up in dipstickshows early damage to kidney - time to treat! Delay or stop progression of damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is proteinuria?

A

300-1000mg of Albumindipstick will turn positiveProtein to Cr ratio will be 1-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does 4+ proteinuria indicate?

A

nephrotic!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes transient proteinuria?

A

exercise, fever, postural proteinuria, dehydration, cold exposure, stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Criteria for nephrotic syndrome

A
  • Al/Cr range >4
  • Edema
  • Decreased serum albumin
  • Reflexive hyperlipidemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the major classifications of nephrotic syndrome?

A

Diabetes, Lupus, Drugs, InfectionsHTN does not cause nephrotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Stages of CKD

A
  • 1 – protein in urine, normal GFR >90
  • 2 – protein in urine GFR 60-89
  • 3a – GFR 45-59
  • 3b – GFR 30-44
  • 4 – GFR 15-29
  • 5 – FGR
    must persist >3mo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CKD and salt

A

for BP control, almost always need salt restriction: 2 g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CKD and protein

A

Protein:

  • St 1-2: no restriction
    St 3-4: restrict
  • high protein also –> high salt, aci precursors, phosphates. Can lead to metabolic acidosis, hyperkalemia, hyperphospathemia, edema, HTN, uremic sx
    Recommended: 0.8 g protein/kg ofideal body weight(actual wt may be d/t edema or obesity)
    if uremic sx persist - 0.6g/kg/day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CKD and caloric intake

A

St 3-4:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Medication assessment for CKD patient should include

A

At every visit:

  • Dosage adjustment based on level of kidney function;
  • Detection of potentially adverse effects on kidney function or complications of chronic kidney disease;
  • Detection of drug interactions;
  • Therapeutic drug monitoring, if possible.
    (KDOQI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is theClassification of Kidney Disease Outcome Quality Initiative?

A

through the NKFThis program providesevidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Patients with GFR

A
  • Anemia (hemoglobin);
  • Nutritional status (dietary energy and protein intake, weight, serum albumin, serum total cholesterol);
  • Bone disease (parathyroid hormone, calcium, phosphorus);
  • Functioning and well-being (questionnaires).
    (KDOQI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Estimated GFR should be monitored yearly in patients with chronic kidney disease, and more frequently in patients with:

A
  • GFR
  • Fast GFR decline in the past (4 mL/min/1.73 m2)
  • Risk factors for faster progression
  • Ongoing treatment to slow progression
  • Exposure to risk factors for acute GFR decline.
    (KDOQI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What to watch out for with DM and CKD

A

Individuals with diabetic kidney disease are at higher risk of diabetic complications, including retinopathy, cardiovascular disease, and neuropathy.They should be evaluated and managed according to established guidelines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Individuals at increased risk for CKDshould be tested at the time of a health evaluations to determine if they have CKD. These include individuals with:

A
  • Diabetes;
  • Hypertension;
  • Autoimmune diseases;
  • Systemic infections;
  • Exposure to drugs or procedures associated with acute decline in kidney function;
  • Recovery from acute kidney failure;
  • Age >60 years;
  • Family history of kidney disease;
  • Reduced kidney mass (includes kidney donors and transplant recipients).
    (KDOQI)
17
Q

Measurements used to determine presence of CKD

A
  • Serum creatinine for estimation of GFR *primary parameter
  • Assessment of proteinuria;
  • Urinary sediment or urine dipstick for red blood cells and white blood cells.
    (KDOQI)
18
Q

When should preparation for kidney replacement therapy (dialysis and transplantation), as well as vascular access care,be initiated?

A

when the estimated GFR declines to (KDOQI)

19
Q

Treatments to slow progression of ckd in adults

A
  • ACE/ARB
  • Strict glycemic control (if diabetic)
  • Strict BP control
  • Dietary protein restriction? (inconclusive evidence)
    (KDOQI)